Literature DB >> 6271367

The specific capsular polysaccharide of Streptococcus pneumoniae type 9V.

M B Perry, V Daoust, D J Carlo.   

Abstract

The specific capsular polysaccharide produced by Streptococcus pneumoniae type 9V (American type 68) is composed of D-glucuronic acid (1 part), D-galactose (1 part), 2-acetamido-2-deoxy-D-mannose (1 part), D-glucose (2 parts), and O-acetyl (1.6 parts). Methylation, periodate oxidation, optical rotation, and nuclear magnetic resonance studies, and partial hydrolysis showed that the polysaccharide is an unbranched high molecular weight linear polymer of a partially O-acetylated pentasaccharide repeating unit having the structure indicated below. (Formula: see text).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271367     DOI: 10.1139/o81-073

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  8 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Precipitating cross-reactions among pneumococcal types.

Authors:  M Heidelberger
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

3.  Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques.

Authors:  T B McNeely; J M Staub; C M Rusk; M J Blum; J J Donnelly
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.

Authors:  C H Lu; C J Lee; P Kind
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

5.  A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.

Authors:  Fang Gao; Kay Lockyer; Karena Burkin; Dennis T Crane; Barbara Bolgiano
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

6.  Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Authors:  Allison E B Turner; Jonas E Gerson; Helen Y So; Daniel J Krasznai; Adrienne J St Hilaire; Donald F Gerson
Journal:  Synth Syst Biotechnol       Date:  2017-01-20

7.  Synthesis of Streptococcus pneumoniae serotype 9V oligosaccharide antigens.

Authors:  Sharavathi G Parameswarappa; Claney L Pereira; Peter H Seeberger
Journal:  Beilstein J Org Chem       Date:  2020-07-15       Impact factor: 2.883

Review 8.  Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.

Authors:  Francesco Berti; Riccardo De Ricco; Rino Rappuoli
Journal:  Molecules       Date:  2018-06-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.